Results 11 to 20 of about 29,761 (232)

Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS) [PDF]

Scientific Reports
Progestogens commonly used in the clinic include levonorgestrel, etonogestrel, medroxyprogesterone, hydroxyprogesterone, progesterone, desogestrel, and megestrol.
Hui Gao, Xiaohan Zhai, Yan Hu, Hang Wu
doaj   +2 more sources

A case report and literature review: A 19‐year‐old with endometrial carcinoma treated with medroxyprogesterone acetate. Importance of the medical interview and endometrial examination [PDF]

Clinical Case Reports
Key Clinical Message A 19‐year‐old woman had stage IA endometrial carcinoma treated with medroxyprogesterone acetate and experienced a recurrence. This patient's experience illustrates the importance of a thorough history and endometrial assessment in ...
Shinichiro Katsuma, Kazuya Ariyoshi, Ai Nio, Kenichi Taguchi, Kenzo Sonoda   +4 more
doaj   +2 more sources

The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma [PDF]

BMC Medical Imaging
Background It will be important to noninvasively evaluate the efficacy of treatment for patients with atypical endometrial hyperplasia (AEH) and endometrial carcinoma (EC) who wish to have children. The study aimed to explore the feasibility of diffusion-
Mingming Liu, Xingzheng Zheng, Na Mo, Yang Liu, Erhu Jin, Yuting Liang   +5 more
doaj   +2 more sources

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response

Frontiers in Endocrinology, 2021
ObjectiveTo compare the clinical outcomes of dydrogesterone (DYG) and medroxyprogesterone (MPA) in the progestin-primed ovarian stimulation (PPOS) protocol for patients with poor ovarian response (POR).Patients and MethodsThis was a retrospective cohort ...
Junwei Zhang, Mingze Du, Zhen Li, Wenxia Liu, Bingnan Ren, Yuchao Zhang, Yichun Guan   +6 more
doaj   +1 more source

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. [PDF]

, 2020
Progestins are widely used for the treatment of gynecologic disorders and alone, or combined with an estrogen, are used as contraceptives. While their potencies, efficacies and side effects vary due to differences in structures, doses and routes of ...
Balayan, Shayna, Chen, Joseph C, Giudice, Linda C, Greenblatt, Ruth M, Houshdaran, Sahar, Irwin, Juan C, Smith-McCune, Karen, Vallvé-Juanico, Júlia, Vo, Kim Chi   +8 more
core   +2 more sources

Medroxyprogesterone acetate improves propionic acid-induced autism rat model and magnetic resonance spectroscopic correlation

Bangladesh Journal of Pharmacology, 2022
The protective effect of medroxyprogesterone acetate on propionic acid-induced autism in rats was evaluated. For this purpose, 30 rats were divided into three groups.
Mehmet Fatih Bozkurt, Muhammad Nasir Bhaya, İbrahim Halil Sever, Bahattin Özkul, Oytun Erbaş   +4 more
doaj   +1 more source

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery

Pharmaceutics, 2020
Following oral administration, the bioavailability of progestogens is very low and highly variable, in part due to metabolism by cytochrome P450 enzymes found in the mucosa of the small intestine.
Zoe Coombes, Vipul Yadav, Laura E. McCoubrey, Cristina Freire, Abdul W. Basit, R. Steven Conlan, Deyarina Gonzalez   +6 more
doaj   +1 more source

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial

Medicina, 2022
Background and objectives: Abnormal uterine bleeding is a significant clinical and gynaecological concern that necessitates its safe and effective treatment.
Suhail Ahmad Mir, Rifat Ara, Fiza Amin, Anjum Malik, Laraibah Hamid, Tabasum Ali, Ghulam Nabi Bader, Shahid Ud Din Wani, Mansour Almuqbil, Sultan Alshehri, Abdulhakeem M. Alshehri, Faiyaz Shakeel   +11 more
doaj   +1 more source

Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients. [PDF]

J Gynecol Oncol
Kitazawa S, Sakai K, Kawaida M, Chiyoda T, Nishio H, Banno K, Susumu N, Yamagami W.   +7 more
europepmc   +3 more sources

Use of depot medroxyprogesterone acetate and fracture risk [PDF]

, 2010
Depot medroxyprogesterone acetate (DMPA), which has a high rate of use among teenagers in Europe and the United States, has been associated with impaired bone mineral acquisition during adolescence and accelerated bone loss in later life.
Brauchli, Yolanda B., Jick, Susan S., Kraenzlin, Marius E., Meier, Christian, Meier, Christoph R.   +4 more
core   +1 more source